nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethoprim—DHFR—Methotrexate—ankylosing spondylitis	0.309	0.343	CbGbCtD
Trimethoprim—TYMS—Methotrexate—ankylosing spondylitis	0.215	0.239	CbGbCtD
Trimethoprim—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0544	0.0603	CbGbCtD
Trimethoprim—ABCB1—Betamethasone—ankylosing spondylitis	0.0354	0.0392	CbGbCtD
Trimethoprim—ABCB1—Prednisolone—ankylosing spondylitis	0.0349	0.0387	CbGbCtD
Trimethoprim—ABCB1—Prednisone—ankylosing spondylitis	0.0329	0.0365	CbGbCtD
Trimethoprim—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0326	0.0361	CbGbCtD
Trimethoprim—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0304	0.0337	CbGbCtD
Trimethoprim—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0247	0.0274	CbGbCtD
Trimethoprim—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0212	0.0235	CbGbCtD
Trimethoprim—CYP3A4—Betamethasone—ankylosing spondylitis	0.0212	0.0235	CbGbCtD
Trimethoprim—CYP3A4—Prednisolone—ankylosing spondylitis	0.0209	0.0232	CbGbCtD
Trimethoprim—ABCB1—Dexamethasone—ankylosing spondylitis	0.0206	0.0228	CbGbCtD
Trimethoprim—CYP3A4—Prednisone—ankylosing spondylitis	0.0197	0.0219	CbGbCtD
Trimethoprim—ABCB1—Methotrexate—ankylosing spondylitis	0.0165	0.0183	CbGbCtD
Trimethoprim—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0123	0.0137	CbGbCtD
Trimethoprim—Pancreatitis—Prednisone—ankylosing spondylitis	0.000366	0.00403	CcSEcCtD
Trimethoprim—Erythema—Prednisolone—ankylosing spondylitis	0.000358	0.00394	CcSEcCtD
Trimethoprim—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.000353	0.00388	CcSEcCtD
Trimethoprim—Neutropenia—Prednisone—ankylosing spondylitis	0.000349	0.00384	CcSEcCtD
Trimethoprim—Hallucination—Dexamethasone—ankylosing spondylitis	0.000342	0.00376	CcSEcCtD
Trimethoprim—Hallucination—Betamethasone—ankylosing spondylitis	0.000342	0.00376	CcSEcCtD
Trimethoprim—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.000341	0.00375	CcSEcCtD
Trimethoprim—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.00034	0.00374	CcSEcCtD
Trimethoprim—Ataxia—Methotrexate—ankylosing spondylitis	0.00034	0.00374	CcSEcCtD
Trimethoprim—Depression—Prednisone—ankylosing spondylitis	0.000332	0.00365	CcSEcCtD
Trimethoprim—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.000331	0.00364	CcSEcCtD
Trimethoprim—Erythema—Triamcinolone—ankylosing spondylitis	0.000329	0.00362	CcSEcCtD
Trimethoprim—Erythema—Methylprednisolone—ankylosing spondylitis	0.000329	0.00361	CcSEcCtD
Trimethoprim—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.000329	0.00361	CcSEcCtD
Trimethoprim—Angioedema—Prednisolone—ankylosing spondylitis	0.000327	0.0036	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.000326	0.00359	CcSEcCtD
Trimethoprim—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.000325	0.00358	CcSEcCtD
Trimethoprim—Vertigo—Prednisolone—ankylosing spondylitis	0.000322	0.00354	CcSEcCtD
Trimethoprim—Syncope—Prednisolone—ankylosing spondylitis	0.000321	0.00353	CcSEcCtD
Trimethoprim—Eye disorder—Betamethasone—ankylosing spondylitis	0.000321	0.00353	CcSEcCtD
Trimethoprim—Eye disorder—Dexamethasone—ankylosing spondylitis	0.000321	0.00353	CcSEcCtD
Trimethoprim—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.000315	0.00346	CcSEcCtD
Trimethoprim—Convulsion—Prednisolone—ankylosing spondylitis	0.00031	0.00341	CcSEcCtD
Trimethoprim—Eosinophilia—Methotrexate—ankylosing spondylitis	0.000309	0.0034	CcSEcCtD
Trimethoprim—Pancreatitis—Methotrexate—ankylosing spondylitis	0.000306	0.00337	CcSEcCtD
Trimethoprim—Angioedema—Triamcinolone—ankylosing spondylitis	0.000301	0.00331	CcSEcCtD
Trimethoprim—Angioedema—Methylprednisolone—ankylosing spondylitis	0.0003	0.0033	CcSEcCtD
Trimethoprim—Erythema—Betamethasone—ankylosing spondylitis	0.000299	0.00329	CcSEcCtD
Trimethoprim—Erythema—Dexamethasone—ankylosing spondylitis	0.000299	0.00329	CcSEcCtD
Trimethoprim—Hallucination—Prednisone—ankylosing spondylitis	0.000297	0.00327	CcSEcCtD
Trimethoprim—Pancytopenia—Methotrexate—ankylosing spondylitis	0.000296	0.00326	CcSEcCtD
Trimethoprim—Vertigo—Triamcinolone—ankylosing spondylitis	0.000296	0.00325	CcSEcCtD
Trimethoprim—Syncope—Triamcinolone—ankylosing spondylitis	0.000295	0.00325	CcSEcCtD
Trimethoprim—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000295	0.00325	CcSEcCtD
Trimethoprim—Syncope—Methylprednisolone—ankylosing spondylitis	0.000295	0.00324	CcSEcCtD
Trimethoprim—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000294	0.00323	CcSEcCtD
Trimethoprim—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000292	0.00322	CcSEcCtD
Trimethoprim—Neutropenia—Methotrexate—ankylosing spondylitis	0.000292	0.00321	CcSEcCtD
Trimethoprim—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000289	0.00318	CcSEcCtD
Trimethoprim—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000289	0.00318	CcSEcCtD
Trimethoprim—Shock—Prednisolone—ankylosing spondylitis	0.000288	0.00316	CcSEcCtD
Trimethoprim—Cough—Triamcinolone—ankylosing spondylitis	0.000287	0.00316	CcSEcCtD
Trimethoprim—Convulsion—Triamcinolone—ankylosing spondylitis	0.000285	0.00314	CcSEcCtD
Trimethoprim—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.000285	0.00313	CcSEcCtD
Trimethoprim—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000285	0.00313	CcSEcCtD
Trimethoprim—Myalgia—Triamcinolone—ankylosing spondylitis	0.00028	0.00308	CcSEcCtD
Trimethoprim—Pneumonia—Methotrexate—ankylosing spondylitis	0.00028	0.00308	CcSEcCtD
Trimethoprim—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00028	0.00308	CcSEcCtD
Trimethoprim—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00028	0.00308	CcSEcCtD
Trimethoprim—Eye disorder—Prednisone—ankylosing spondylitis	0.000279	0.00307	CcSEcCtD
Trimethoprim—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000279	0.00307	CcSEcCtD
Trimethoprim—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000278	0.00306	CcSEcCtD
Trimethoprim—Infestation—Methotrexate—ankylosing spondylitis	0.000278	0.00306	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000278	0.00306	CcSEcCtD
Trimethoprim—Depression—Methotrexate—ankylosing spondylitis	0.000278	0.00305	CcSEcCtD
Trimethoprim—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000276	0.00304	CcSEcCtD
Trimethoprim—Renal failure—Methotrexate—ankylosing spondylitis	0.000274	0.00301	CcSEcCtD
Trimethoprim—Angioedema—Dexamethasone—ankylosing spondylitis	0.000273	0.003	CcSEcCtD
Trimethoprim—Angioedema—Betamethasone—ankylosing spondylitis	0.000273	0.003	CcSEcCtD
Trimethoprim—Stomatitis—Methotrexate—ankylosing spondylitis	0.000271	0.00298	CcSEcCtD
Trimethoprim—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00027	0.00297	CcSEcCtD
Trimethoprim—Immune system disorder—Prednisone—ankylosing spondylitis	0.00027	0.00297	CcSEcCtD
Trimethoprim—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000269	0.00296	CcSEcCtD
Trimethoprim—Vertigo—Betamethasone—ankylosing spondylitis	0.000268	0.00295	CcSEcCtD
Trimethoprim—Vertigo—Dexamethasone—ankylosing spondylitis	0.000268	0.00295	CcSEcCtD
Trimethoprim—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000268	0.00295	CcSEcCtD
Trimethoprim—Syncope—Betamethasone—ankylosing spondylitis	0.000268	0.00295	CcSEcCtD
Trimethoprim—Syncope—Dexamethasone—ankylosing spondylitis	0.000268	0.00295	CcSEcCtD
Trimethoprim—Haematuria—Methotrexate—ankylosing spondylitis	0.000265	0.00292	CcSEcCtD
Trimethoprim—Shock—Triamcinolone—ankylosing spondylitis	0.000264	0.00291	CcSEcCtD
Trimethoprim—Insomnia—Prednisolone—ankylosing spondylitis	0.000264	0.00291	CcSEcCtD
Trimethoprim—Shock—Methylprednisolone—ankylosing spondylitis	0.000264	0.0029	CcSEcCtD
Trimethoprim—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000263	0.0029	CcSEcCtD
Trimethoprim—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000263	0.00289	CcSEcCtD
Trimethoprim—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000263	0.00289	CcSEcCtD
Trimethoprim—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000263	0.00289	CcSEcCtD
Trimethoprim—Epistaxis—Methotrexate—ankylosing spondylitis	0.000263	0.00289	CcSEcCtD
Trimethoprim—Mental disorder—Prednisone—ankylosing spondylitis	0.000262	0.00288	CcSEcCtD
Trimethoprim—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00026	0.00287	CcSEcCtD
Trimethoprim—Erythema—Prednisone—ankylosing spondylitis	0.00026	0.00286	CcSEcCtD
Trimethoprim—Malnutrition—Prednisone—ankylosing spondylitis	0.00026	0.00286	CcSEcCtD
Trimethoprim—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.00026	0.00286	CcSEcCtD
Trimethoprim—Convulsion—Betamethasone—ankylosing spondylitis	0.000259	0.00285	CcSEcCtD
Trimethoprim—Convulsion—Dexamethasone—ankylosing spondylitis	0.000259	0.00285	CcSEcCtD
Trimethoprim—Myalgia—Betamethasone—ankylosing spondylitis	0.000254	0.0028	CcSEcCtD
Trimethoprim—Myalgia—Dexamethasone—ankylosing spondylitis	0.000254	0.0028	CcSEcCtD
Trimethoprim—Anxiety—Betamethasone—ankylosing spondylitis	0.000254	0.00279	CcSEcCtD
Trimethoprim—Anxiety—Dexamethasone—ankylosing spondylitis	0.000254	0.00279	CcSEcCtD
Trimethoprim—TYMS—Clobetasol propionate—Methylprednisolone—ankylosing spondylitis	0.000249	0.0331	CbGdCrCtD
Trimethoprim—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000247	0.00271	CcSEcCtD
Trimethoprim—TYMS—Flunisolide—Methylprednisolone—ankylosing spondylitis	0.000246	0.0327	CbGdCrCtD
Trimethoprim—TYMS—Clobetasol propionate—Betamethasone—ankylosing spondylitis	0.000245	0.0326	CbGdCrCtD
Trimethoprim—TYMS—Clobetasol propionate—Dexamethasone—ankylosing spondylitis	0.000245	0.0326	CbGdCrCtD
Trimethoprim—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000245	0.00269	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000245	0.00269	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000244	0.00269	CcSEcCtD
Trimethoprim—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000244	0.00268	CcSEcCtD
Trimethoprim—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000244	0.00268	CcSEcCtD
Trimethoprim—TYMS—Triamcinolone—Methylprednisolone—ankylosing spondylitis	0.000244	0.0324	CbGdCrCtD
Trimethoprim—Insomnia—Triamcinolone—ankylosing spondylitis	0.000243	0.00267	CcSEcCtD
Trimethoprim—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000243	0.00267	CcSEcCtD
Trimethoprim—TYMS—Flunisolide—Dexamethasone—ankylosing spondylitis	0.000242	0.0322	CbGdCrCtD
Trimethoprim—TYMS—Flunisolide—Betamethasone—ankylosing spondylitis	0.000242	0.0322	CbGdCrCtD
Trimethoprim—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000241	0.00265	CcSEcCtD
Trimethoprim—Shock—Betamethasone—ankylosing spondylitis	0.00024	0.00264	CcSEcCtD
Trimethoprim—Shock—Dexamethasone—ankylosing spondylitis	0.00024	0.00264	CcSEcCtD
Trimethoprim—TYMS—Clobetasol propionate—Triamcinolone—ankylosing spondylitis	0.00024	0.0319	CbGdCrCtD
Trimethoprim—TYMS—Triamcinolone—Dexamethasone—ankylosing spondylitis	0.00024	0.0319	CbGdCrCtD
Trimethoprim—TYMS—Triamcinolone—Betamethasone—ankylosing spondylitis	0.00024	0.0319	CbGdCrCtD
Trimethoprim—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00024	0.00264	CcSEcCtD
Trimethoprim—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000239	0.00263	CcSEcCtD
Trimethoprim—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000239	0.00263	CcSEcCtD
Trimethoprim—Agitation—Prednisone—ankylosing spondylitis	0.000239	0.00263	CcSEcCtD
Trimethoprim—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000239	0.00263	CcSEcCtD
Trimethoprim—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000239	0.00263	CcSEcCtD
Trimethoprim—Angioedema—Prednisone—ankylosing spondylitis	0.000238	0.00262	CcSEcCtD
Trimethoprim—TYMS—Fluticasone Propionate—Methylprednisolone—ankylosing spondylitis	0.000237	0.0316	CbGdCrCtD
Trimethoprim—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000237	0.0026	CcSEcCtD
Trimethoprim—TYMS—Flunisolide—Triamcinolone—ankylosing spondylitis	0.000237	0.0315	CbGdCrCtD
Trimethoprim—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000236	0.0026	CcSEcCtD
Trimethoprim—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000236	0.0026	CcSEcCtD
Trimethoprim—Vertigo—Prednisone—ankylosing spondylitis	0.000234	0.00257	CcSEcCtD
Trimethoprim—TYMS—Fluticasone Propionate—Betamethasone—ankylosing spondylitis	0.000234	0.0311	CbGdCrCtD
Trimethoprim—TYMS—Fluticasone Propionate—Dexamethasone—ankylosing spondylitis	0.000234	0.0311	CbGdCrCtD
Trimethoprim—Eye disorder—Methotrexate—ankylosing spondylitis	0.000233	0.00257	CcSEcCtD
Trimethoprim—Syncope—Prednisone—ankylosing spondylitis	0.000233	0.00257	CcSEcCtD
Trimethoprim—Tinnitus—Methotrexate—ankylosing spondylitis	0.000233	0.00256	CcSEcCtD
Trimethoprim—Anorexia—Betamethasone—ankylosing spondylitis	0.000232	0.00256	CcSEcCtD
Trimethoprim—Anorexia—Dexamethasone—ankylosing spondylitis	0.000232	0.00256	CcSEcCtD
Trimethoprim—Urticaria—Prednisolone—ankylosing spondylitis	0.000232	0.00255	CcSEcCtD
Trimethoprim—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000229	0.00252	CcSEcCtD
Trimethoprim—TYMS—Fluticasone Propionate—Triamcinolone—ankylosing spondylitis	0.000228	0.0304	CbGdCrCtD
Trimethoprim—TYMS—Clobetasol propionate—Prednisone—ankylosing spondylitis	0.000227	0.0302	CbGdCrCtD
Trimethoprim—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000226	0.00248	CcSEcCtD
Trimethoprim—Convulsion—Prednisone—ankylosing spondylitis	0.000225	0.00248	CcSEcCtD
Trimethoprim—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000225	0.00248	CcSEcCtD
Trimethoprim—TYMS—Flunisolide—Prednisone—ankylosing spondylitis	0.000225	0.0299	CbGdCrCtD
Trimethoprim—TYMS—Diflorasone—Methylprednisolone—ankylosing spondylitis	0.000224	0.0298	CbGdCrCtD
Trimethoprim—TYMS—Triamcinolone—Prednisone—ankylosing spondylitis	0.000222	0.0295	CbGdCrCtD
Trimethoprim—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000222	0.00244	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000222	0.00244	CcSEcCtD
Trimethoprim—TYMS—Clobetasol propionate—Prednisolone—ankylosing spondylitis	0.000222	0.0295	CbGdCrCtD
Trimethoprim—Myalgia—Prednisone—ankylosing spondylitis	0.000222	0.00244	CcSEcCtD
Trimethoprim—Arthralgia—Prednisone—ankylosing spondylitis	0.000222	0.00244	CcSEcCtD
Trimethoprim—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000221	0.00244	CcSEcCtD
Trimethoprim—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000221	0.00243	CcSEcCtD
Trimethoprim—TYMS—Diflorasone—Betamethasone—ankylosing spondylitis	0.000221	0.0294	CbGdCrCtD
Trimethoprim—TYMS—Diflorasone—Dexamethasone—ankylosing spondylitis	0.000221	0.0294	CbGdCrCtD
Trimethoprim—Anxiety—Prednisone—ankylosing spondylitis	0.000221	0.00243	CcSEcCtD
Trimethoprim—Insomnia—Betamethasone—ankylosing spondylitis	0.000221	0.00243	CcSEcCtD
Trimethoprim—Insomnia—Dexamethasone—ankylosing spondylitis	0.000221	0.00243	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00022	0.00242	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000219	0.00241	CcSEcCtD
Trimethoprim—TYMS—Flunisolide—Prednisolone—ankylosing spondylitis	0.000219	0.0291	CbGdCrCtD
Trimethoprim—Mental disorder—Methotrexate—ankylosing spondylitis	0.000219	0.00241	CcSEcCtD
Trimethoprim—Erythema—Methotrexate—ankylosing spondylitis	0.000217	0.00239	CcSEcCtD
Trimethoprim—Malnutrition—Methotrexate—ankylosing spondylitis	0.000217	0.00239	CcSEcCtD
Trimethoprim—TYMS—Triamcinolone—Prednisolone—ankylosing spondylitis	0.000217	0.0288	CbGdCrCtD
Trimethoprim—TYMS—Diflorasone—Triamcinolone—ankylosing spondylitis	0.000216	0.0287	CbGdCrCtD
Trimethoprim—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000215	0.00237	CcSEcCtD
Trimethoprim—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000215	0.00236	CcSEcCtD
Trimethoprim—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000215	0.00236	CcSEcCtD
Trimethoprim—Urticaria—Triamcinolone—ankylosing spondylitis	0.000214	0.00235	CcSEcCtD
Trimethoprim—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000213	0.00234	CcSEcCtD
Trimethoprim—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000212	0.00234	CcSEcCtD
Trimethoprim—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000212	0.00234	CcSEcCtD
Trimethoprim—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000212	0.00233	CcSEcCtD
Trimethoprim—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000212	0.00233	CcSEcCtD
Trimethoprim—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000212	0.00233	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000211	0.00232	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000211	0.00232	CcSEcCtD
Trimethoprim—Shock—Prednisone—ankylosing spondylitis	0.000209	0.0023	CcSEcCtD
Trimethoprim—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000208	0.00229	CcSEcCtD
Trimethoprim—Skin disorder—Prednisone—ankylosing spondylitis	0.000206	0.00227	CcSEcCtD
Trimethoprim—TYMS—Diflorasone—Prednisone—ankylosing spondylitis	0.000205	0.0272	CbGdCrCtD
Trimethoprim—Anorexia—Prednisone—ankylosing spondylitis	0.000202	0.00223	CcSEcCtD
Trimethoprim—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000201	0.00221	CcSEcCtD
Trimethoprim—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000201	0.00221	CcSEcCtD
Trimethoprim—TYMS—Diflorasone—Prednisolone—ankylosing spondylitis	0.0002	0.0266	CbGdCrCtD
Trimethoprim—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000199	0.00219	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000199	0.00219	CcSEcCtD
Trimethoprim—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000198	0.00218	CcSEcCtD
Trimethoprim—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000198	0.00217	CcSEcCtD
Trimethoprim—TYMS—Budesonide—Methylprednisolone—ankylosing spondylitis	0.000197	0.0262	CbGdCrCtD
Trimethoprim—Vertigo—Methotrexate—ankylosing spondylitis	0.000195	0.00215	CcSEcCtD
Trimethoprim—Leukopenia—Methotrexate—ankylosing spondylitis	0.000195	0.00214	CcSEcCtD
Trimethoprim—Urticaria—Betamethasone—ankylosing spondylitis	0.000194	0.00213	CcSEcCtD
Trimethoprim—Urticaria—Dexamethasone—ankylosing spondylitis	0.000194	0.00213	CcSEcCtD
Trimethoprim—TYMS—Budesonide—Dexamethasone—ankylosing spondylitis	0.000194	0.0257	CbGdCrCtD
Trimethoprim—TYMS—Budesonide—Betamethasone—ankylosing spondylitis	0.000194	0.0257	CbGdCrCtD
Trimethoprim—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000194	0.00213	CcSEcCtD
Trimethoprim—Dizziness—Prednisolone—ankylosing spondylitis	0.000193	0.00213	CcSEcCtD
Trimethoprim—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000193	0.00212	CcSEcCtD
Trimethoprim—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000193	0.00212	CcSEcCtD
Trimethoprim—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000193	0.00212	CcSEcCtD
Trimethoprim—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000193	0.00212	CcSEcCtD
Trimethoprim—Insomnia—Prednisone—ankylosing spondylitis	0.000192	0.00211	CcSEcCtD
Trimethoprim—Pruritus—Triamcinolone—ankylosing spondylitis	0.00019	0.00209	CcSEcCtD
Trimethoprim—Cough—Methotrexate—ankylosing spondylitis	0.00019	0.00209	CcSEcCtD
Trimethoprim—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00019	0.00209	CcSEcCtD
Trimethoprim—TYMS—Budesonide—Triamcinolone—ankylosing spondylitis	0.000189	0.0252	CbGdCrCtD
Trimethoprim—Convulsion—Methotrexate—ankylosing spondylitis	0.000188	0.00207	CcSEcCtD
Trimethoprim—Dyspepsia—Prednisone—ankylosing spondylitis	0.000187	0.00206	CcSEcCtD
Trimethoprim—Arthralgia—Methotrexate—ankylosing spondylitis	0.000185	0.00204	CcSEcCtD
Trimethoprim—Myalgia—Methotrexate—ankylosing spondylitis	0.000185	0.00204	CcSEcCtD
Trimethoprim—Decreased appetite—Prednisone—ankylosing spondylitis	0.000185	0.00203	CcSEcCtD
Trimethoprim—Rash—Prednisolone—ankylosing spondylitis	0.000184	0.00203	CcSEcCtD
Trimethoprim—Dermatitis—Prednisolone—ankylosing spondylitis	0.000184	0.00203	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000184	0.00202	CcSEcCtD
Trimethoprim—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000183	0.00202	CcSEcCtD
Trimethoprim—Headache—Prednisolone—ankylosing spondylitis	0.000183	0.00201	CcSEcCtD
Trimethoprim—Constipation—Prednisone—ankylosing spondylitis	0.000182	0.002	CcSEcCtD
Trimethoprim—TYMS—Budesonide—Prednisone—ankylosing spondylitis	0.00018	0.0239	CbGdCrCtD
Trimethoprim—Confusional state—Methotrexate—ankylosing spondylitis	0.000179	0.00197	CcSEcCtD
Trimethoprim—Dizziness—Triamcinolone—ankylosing spondylitis	0.000178	0.00196	CcSEcCtD
Trimethoprim—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000177	0.00195	CcSEcCtD
Trimethoprim—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000177	0.00195	CcSEcCtD
Trimethoprim—TYMS—Budesonide—Prednisolone—ankylosing spondylitis	0.000175	0.0233	CbGdCrCtD
Trimethoprim—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000175	0.00193	CcSEcCtD
Trimethoprim—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000174	0.00191	CcSEcCtD
Trimethoprim—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000174	0.00191	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000174	0.00191	CcSEcCtD
Trimethoprim—Nausea—Prednisolone—ankylosing spondylitis	0.000174	0.00191	CcSEcCtD
Trimethoprim—Pruritus—Betamethasone—ankylosing spondylitis	0.000173	0.0019	CcSEcCtD
Trimethoprim—Pruritus—Dexamethasone—ankylosing spondylitis	0.000173	0.0019	CcSEcCtD
Trimethoprim—Skin disorder—Methotrexate—ankylosing spondylitis	0.000172	0.0019	CcSEcCtD
Trimethoprim—TYMS—Danazol—Prednisone—ankylosing spondylitis	0.000172	0.0229	CbGdCrCtD
Trimethoprim—Vomiting—Triamcinolone—ankylosing spondylitis	0.000171	0.00188	CcSEcCtD
Trimethoprim—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000171	0.00188	CcSEcCtD
Trimethoprim—Rash—Triamcinolone—ankylosing spondylitis	0.000169	0.00186	CcSEcCtD
Trimethoprim—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000169	0.00186	CcSEcCtD
Trimethoprim—Anorexia—Methotrexate—ankylosing spondylitis	0.000169	0.00186	CcSEcCtD
Trimethoprim—Rash—Methylprednisolone—ankylosing spondylitis	0.000169	0.00186	CcSEcCtD
Trimethoprim—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000169	0.00186	CcSEcCtD
Trimethoprim—Urticaria—Prednisone—ankylosing spondylitis	0.000169	0.00186	CcSEcCtD
Trimethoprim—Headache—Triamcinolone—ankylosing spondylitis	0.000168	0.00185	CcSEcCtD
Trimethoprim—Headache—Methylprednisolone—ankylosing spondylitis	0.000168	0.00185	CcSEcCtD
Trimethoprim—Abdominal pain—Prednisone—ankylosing spondylitis	0.000168	0.00185	CcSEcCtD
Trimethoprim—Body temperature increased—Prednisone—ankylosing spondylitis	0.000168	0.00185	CcSEcCtD
Trimethoprim—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000167	0.00184	CcSEcCtD
Trimethoprim—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000167	0.00184	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000162	0.00178	CcSEcCtD
Trimethoprim—Dizziness—Betamethasone—ankylosing spondylitis	0.000161	0.00177	CcSEcCtD
Trimethoprim—Dizziness—Dexamethasone—ankylosing spondylitis	0.000161	0.00177	CcSEcCtD
Trimethoprim—Insomnia—Methotrexate—ankylosing spondylitis	0.000161	0.00177	CcSEcCtD
Trimethoprim—Nausea—Triamcinolone—ankylosing spondylitis	0.00016	0.00176	CcSEcCtD
Trimethoprim—Nausea—Methylprednisolone—ankylosing spondylitis	0.000159	0.00175	CcSEcCtD
Trimethoprim—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000158	0.00174	CcSEcCtD
Trimethoprim—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000156	0.00172	CcSEcCtD
Trimethoprim—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000156	0.00172	CcSEcCtD
Trimethoprim—Vomiting—Dexamethasone—ankylosing spondylitis	0.000155	0.00171	CcSEcCtD
Trimethoprim—Vomiting—Betamethasone—ankylosing spondylitis	0.000155	0.00171	CcSEcCtD
Trimethoprim—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000154	0.0017	CcSEcCtD
Trimethoprim—Rash—Dexamethasone—ankylosing spondylitis	0.000154	0.00169	CcSEcCtD
Trimethoprim—Rash—Betamethasone—ankylosing spondylitis	0.000154	0.00169	CcSEcCtD
Trimethoprim—Dermatitis—Betamethasone—ankylosing spondylitis	0.000154	0.00169	CcSEcCtD
Trimethoprim—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000154	0.00169	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000153	0.00169	CcSEcCtD
Trimethoprim—Headache—Betamethasone—ankylosing spondylitis	0.000153	0.00168	CcSEcCtD
Trimethoprim—Headache—Dexamethasone—ankylosing spondylitis	0.000153	0.00168	CcSEcCtD
Trimethoprim—Pruritus—Prednisone—ankylosing spondylitis	0.00015	0.00165	CcSEcCtD
Trimethoprim—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000146	0.00161	CcSEcCtD
Trimethoprim—Diarrhoea—Prednisone—ankylosing spondylitis	0.000145	0.0016	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000145	0.0016	CcSEcCtD
Trimethoprim—Nausea—Dexamethasone—ankylosing spondylitis	0.000145	0.00159	CcSEcCtD
Trimethoprim—Nausea—Betamethasone—ankylosing spondylitis	0.000145	0.00159	CcSEcCtD
Trimethoprim—Urticaria—Methotrexate—ankylosing spondylitis	0.000141	0.00155	CcSEcCtD
Trimethoprim—Dizziness—Prednisone—ankylosing spondylitis	0.00014	0.00155	CcSEcCtD
Trimethoprim—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00014	0.00154	CcSEcCtD
Trimethoprim—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00014	0.00154	CcSEcCtD
Trimethoprim—Vomiting—Prednisone—ankylosing spondylitis	0.000135	0.00149	CcSEcCtD
Trimethoprim—Rash—Prednisone—ankylosing spondylitis	0.000134	0.00147	CcSEcCtD
Trimethoprim—Dermatitis—Prednisone—ankylosing spondylitis	0.000134	0.00147	CcSEcCtD
Trimethoprim—Headache—Prednisone—ankylosing spondylitis	0.000133	0.00146	CcSEcCtD
Trimethoprim—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000131	0.00144	CcSEcCtD
Trimethoprim—Nausea—Prednisone—ankylosing spondylitis	0.000126	0.00139	CcSEcCtD
Trimethoprim—Pruritus—Methotrexate—ankylosing spondylitis	0.000126	0.00138	CcSEcCtD
Trimethoprim—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000121	0.00134	CcSEcCtD
Trimethoprim—Dizziness—Methotrexate—ankylosing spondylitis	0.000117	0.00129	CcSEcCtD
Trimethoprim—Vomiting—Methotrexate—ankylosing spondylitis	0.000113	0.00124	CcSEcCtD
Trimethoprim—Rash—Methotrexate—ankylosing spondylitis	0.000112	0.00123	CcSEcCtD
Trimethoprim—Dermatitis—Methotrexate—ankylosing spondylitis	0.000112	0.00123	CcSEcCtD
Trimethoprim—Headache—Methotrexate—ankylosing spondylitis	0.000111	0.00122	CcSEcCtD
Trimethoprim—Nausea—Methotrexate—ankylosing spondylitis	0.000105	0.00116	CcSEcCtD
